BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 9278187)

  • 1. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.
    Sanyal S; Van Tol HH
    J Psychiatr Res; 1997; 31(2):219-32. PubMed ID: 9278187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J; Eyrolles L; Bruhwyler J; Delarge J
    Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM; Sanyal S; Van Tol HH
    Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P; Corbett R; Van Tol HH
    Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopamine D4-receptor variants, schizophrenia and clozapine therapy].
    Ewald HL; Mors NP; Rosenberg R
    Ugeskr Laeger; 1996 Jun; 158(25):3601-3. PubMed ID: 8693618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of dopamine D4 receptors in the action and development of antipsychotic agents.
    Reynolds GP
    Drugs; 1996 Jan; 51(1):7-11. PubMed ID: 8741229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS; Goldman-Rakic PS
    J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
    Gurevich EV; Bordelon Y; Shapiro RM; Arnold SE; Gur RE; Joyce JN
    Arch Gen Psychiatry; 1997 Mar; 54(3):225-32. PubMed ID: 9075463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
    Seeman P
    Neuropsychopharmacology; 1992 Dec; 7(4):261-84. PubMed ID: 1362057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.
    Rietschel M; Naber D; Oberländer H; Holzbach R; Fimmers R; Eggermann K; Möller HJ; Propping P; Nöthen MM
    Neuropsychopharmacology; 1996 Nov; 15(5):491-6. PubMed ID: 8914122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
    Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
    Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.
    Murray AM; Hyde TM; Knable MB; Herman MM; Bigelow LB; Carter JM; Weinberger DR; Kleinman JE
    J Neurosci; 1995 Mar; 15(3 Pt 2):2186-91. PubMed ID: 7891160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The D2 receptor: love it and leave it.
    Pickar D
    Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
    Reynolds GP
    Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor pharmacology.
    Seeman P; Van Tol HH
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D4 receptors and development of newer antipsychotic drugs.
    Kulkarni SK; Ninan I
    Fundam Clin Pharmacol; 2000; 14(6):529-39. PubMed ID: 11206702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopamine D4 receptor in schizophrenia: an update.
    Kerwin RW; Collier D
    Psychol Med; 1996 Mar; 26(2):221-7. PubMed ID: 8685278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.